Clavulanic Acid
Back to searchMolecule Structure
Scientific Name
Clavulanic Acid
Description of the Drug
Clavulanic acid is a beta lactamase inhibitor used to enhance the effectiveness of beta lactam antibiotics.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00766
http://www.drugbank.ca/drugs/DB00766
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Micro Labs Ltd India, Teva Pharmaceuticals Usa Inc, Wockhardt Bio Ag, Us Antibiotics Llc, Glaxosmithkline, Glaxosmithkline Intellectual Property No 2 Ltd England, Sandoz Inc, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial beta-lactamase TEM | SINGLE PROTEIN | INHIBITOR | CHEMBL2364670 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL6093 | ||
PharmGKB | PA164742987 | ||
Human Metabolome Database | HMDB0014904 | ||
DrugBank | DB00766 | ||
PubChem: Thomson Pharma | 15171670 | 15120937 | |
PubChem | 5280980 | ||
NMRShiftDB | 60072267 | ||
Nikkaji | J14.640D | J1.018.185B | |
PDBe | J01 | ||
BindingDB | 50021959 | ||
EPA CompTox Dashboard | DTXSID2022830 | ||
DrugCentral | 669 | ||
Metabolights | MTBLC48947 | ||
Brenda | 1004 | 6886 | |
ChemicalBook | CB9722501 | ||
Guide to Pharmacology | 11128 | ||
rxnorm | CLAVULANATE | CLAVULANIC ACID | CLAVULANATE POTASSIUM |
KEGG Ligand | C06662 | ||
ChEBI | 48947 | ||
ZINC | ZINC000003830569 |